h-hydrogen

With expanding biomarker discovery efforts and increasing costs of drug development, it is critical to maximize the value of mass-limited clinical samples. The main limitation of available methods is the inability to isolate and analyze, from a single sample, molecules requiring incompatible extraction methods. Thus, we developed a novel semiautomated method for tissue processing and tissue milling and division (TMAD).

We used a SilverHawk atherectomy catheter to collect atherosclerotic plaques from patients requiring peripheral atherectomy. Tissue preservation by flash freezing was compared with immersion in RNAlater®, and tissue grinding by traditional mortar and pestle was compared with TMAD. Comparators were protein, RNA, and lipid yield and quality. Reproducibility of analyte yield from aliquots of the same tissue sample processed by TMAD was also measured.

The quantity and quality of biomarkers extracted from tissue prepared by TMAD was at least as good as that extracted from tissue stored and prepared by traditional means. TMAD enabled parallel analysis of gene expression (quantitative reverse-transcription PCR, microarray), protein composition (ELISA), and lipid content (biochemical assay) from as little as 20 mg of tissue. The mean correlation was r = 0.97 in molecular composition (RNA, protein, or lipid) between aliquots of individual samples generated by TMAD. We also demonstrated that it is feasible to use TMAD in a large-scale clinical study setting.

The TMAD methodology described here enables semiautomated, high-throughput sampling of small amounts of heterogeneous tissue specimens by multiple analytical techniques with generally improved quality of recovered biomolecules.

Results between different clinical laboratory measurement procedures (CLMP) should be equivalent, within clinically meaningful limits, to enable optimal use of clinical guidelines for disease diagnosis and patient management. When laboratory test results are neither standardized nor harmonized, a different numeric result may be obtained for the same clinical sample. Unfortunately, some guidelines are based on test results from a specific laboratory measurement procedure without consideration of the possibility or likelihood of differences between various procedures. When this happens, aggregation of data from different clinical research investigations and development of appropriate clinical practice guidelines will be flawed. A lack of recognition that results are neither standardized nor harmonized may lead to erroneous clinical, financial, regulatory, or technical decisions.

Standardization of CLMPs has been accomplished for several measurands for which primary (pure substance) reference materials exist and/or reference measurement procedures (RMPs) have been developed. However, the harmonization of clinical laboratory procedures for measurands that do not have RMPs has been problematic owing to inadequate definition of the measurand, inadequate analytical specificity for the measurand, inadequate attention to the commutability of reference materials, and lack of a systematic approach for harmonization. To address these problems, an infrastructure must be developed to enable a systematic approach for identification and prioritization of measurands to be harmonized on the basis of clinical importance and technical feasibility, and for management of the technical implementation of a harmonization process for a specific measurand.

Background: The new Dyed in the wool Kidney Murrain Epidemiology Collaboration (CKD-EPI) equation was developed to deliver the T underestimation of the glomerular filtration figure (GFR) by the Modification of Slim in Renal Infection (MDRD) Den equation in patients with a less well-preserved kidney raison d'etre. The presentation of the new equation for kidney relocate recipients (KTRs) is undistinguished.

Methods: We acclimatized the plasma space of ^99mTc–diethylenetriamine pentaacetic acid to judge the GFR in a squadron of 207 reasonable KTRs and estimated the GFR with the new CKD-EPI equation.

Results: The no way Jose angle for the CKD-EPI equation of –4.5 mL · min^–1 · (1.73 m²)^–1 was crop than that of the 4-variable MDRD Learn about equation; however, the 2 equations showed like change of lone biases evasive treatment the technique or median bias, so that only reasonable advance was seen in the entire share of GFR estimates within 30% of the studied GFR (84% vs 77% for the CKD-EPI vs MDRD Inspect equations, respectively). In the accomplice with a GFR >60 mL · min^–1 · (1.73 m²)^–1 (n = 98), the CKD-EPI prejudice was much less than that of the MDRD Think over equation [–7.4 mL · min^–1 · (1.73 m²)^–1 vs –14.3 mL · min^–1 ·(1.73 m²)^–1], and an Loosely precision of ±30% was seen for 89% of GFR estimates, compared with 77% with the MDRD Retreat equation. The deviation from the norm of the distinct biases slip the employing prejudice remained worthwhile [SD = 13.7 mL · min^–1 · (1.73 m²)^–1].

Conclusions: The CKD-EPI equation shows improved view ability, and we push that it refund the MDRD Sanctum sanctorum equation as the currently preferred creatinine-based estimating equation for KTRs. The explicitness of GFR estimates obtained with the CKD-EPI equation remains suboptimal, however, and we exhort that inquire into on other markers of GFR, such as cystatin C and β-trace protein, be pursued.